Meanwhile, the acquisition of AntlerA, which Roche called a leader in Wnt signaling, gives the pharma ownership of a library ...

Cambridge, Massachusetts-based biotech Regor Therapeutics Group has agreed to sell its portfolio of CDK inhibitors for the ...

Genentech to buy Regor's portfolio of next-generation CDK inhibitors to treat breast cancer: Cambridge, Massachusetts Tuesday, October 1, 2024, 10:00 Hrs [IST] Regor Pharmaceutica ...

The Swiss pharma is paying Regor Therapeutics $850 million to buy a pair of prospects it sees as potential successors to blockbuster medicines from Pfizer and Eli Lilly.

Sino-American biotech Regor Pharmaceuticals has entered into a definitive purchase agreement whereby Swiss pharma major Roche ...

Roche is spending $850 million upfront to buy Regor Pharmaceuticals’ suite of next-generation CDK inhibitors as it doubles ...

Regor Pharmaceuticals USA has entered into a definitive purchase agreement, under which Genentech, a member of the Roche Group, will ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

A major cyberattack on CDK Global, a software service used by thousands of car dealerships, is now impacting the public. The ...

If you’re looking to buy a vehicle this week, you might be impacted for "several" more days. Here’s what we know. What is CDK ...

CDK Global reportedly paid $25 million to cybercriminals after a mid-June ransomware attack disrupted business for thousands of car dealerships. According to a report from CNN citing multiple ...

A pair of cyberattacks against software maker CDK continues to impact thousands of car dealerships and has spurred threat actors to launch impersonation attacks. The CDK Global outage affecting ...